Refine search

Search Substrates and Products (Substrate)

Substrates and Products (Substrate): show results

Don't show organism specific information (fast!)

Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)

(Not possible to combine with the first option)

Refine your search

Recommended Name:

EC Number:

Commentary Substrates:

Literature (Substrates):

Organism:

Products:

Commentary (Products):

Reversibility:

Search term:

Results 1 - 10 of 80

EC Number	Substrates	Commentary Substrates	Organism	Products	Commentary (Products)	Reversibility
2.7.1.136	ATP + clarithromycin	46-55% activity with respect to oleandomycin for strain CU1, 17% activity with respect to oleandomycin for strain BM 2506	Escherichia coli	?	-	?
2.7.1.136	ATP + clarithromycin	77% activity with respect to oleandomycin	Pseudomonas aeruginosa	?	-	?
2.7.1.136	ATP + josamycin	2% activity with respect to oleandomycin	Pseudomonas aeruginosa	?	-	?
2.7.1.136	ATP + josamycin	1% activity with respect to oleandomycin	Escherichia coli	?	-	?
2.7.1.136	ATP + josamycin	75-95% activity with respect to oleandomycin for strain CU1, 96% activity with respect to oleandomycin for strain BM 2506	Escherichia coli	?	-	?
2.7.1.136	ATP + kitasamycin	52% activity with respect to oleandomycin for strain CU1, 61% activity with respect to oleandomycin for strain BM 2506	Escherichia coli	?	-	?
2.7.1.136	ATP + midecamycin	3% activity with respect to oleandomycin	Escherichia coli	?	-	?
2.7.1.136	ATP + midecamycin	2% activity with respect to oleandomycin	Pseudomonas aeruginosa	?	-	?
2.7.1.136	ATP + roxithromycin	42% activity with respect to oleandomycin for strain CU1, about 2% activity with respect to oleandomycin for strain BM 2506	Escherichia coli	?	-	?
2.7.1.136	ATP + roxithromycin	44% activity with respect to oleandomycin	Pseudomonas aeruginosa	?	-	?

Results 1 - 10 of 80

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)